Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →12
🟢 Low
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,334
Total Claims
$795K
Drug Cost
614
Beneficiaries
$1,295
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+24%
Opioid rate vs peers
57.0% vs 45.9% avg
+168%
Cost per patient vs peers
$1,295 vs $483 avg
+78%
Brand preference vs peers
7.3% vs 4.1% avg
Opioid Prescribing
57.0%
Opioid Rate
4,752
Opioid Claims
$407K
Opioid Cost
20.4%
Long-Acting Rate
This provider's opioid prescribing rate of 57.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 611 claims · $495K
Generic: 7,723 claims · $300K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 160 | $122K |
| Oxycodone Hcl | 133 | $101K |
| Methylnaltrexone Bromide | 34 | $80K |
| Ubrogepant | 27 | $60K |
| Hydrocodone/Acetaminophen | 1,744 | $52K |
| Buprenorphine Hcl/Naloxone Hcl | 184 | $36K |
| Naloxegol Oxalate | 80 | $32K |
| Oxycodone Hcl/Acetaminophen | 1,067 | $30K |
| Buprenorphine | 73 | $27K |
| Gabapentin | 1,112 | $23K |
| Oxymorphone Hcl | 25 | $19K |
| Pregabalin | 183 | $16K |
| Lidocaine | 23 | $15K |
| Morphine Sulfate | 356 | $13K |
| Diclofenac Sodium | 90 | $13K |
Prescribing Profile
45
Unique Drugs
12.0
Anomaly Score
Patient Profile
68
Avg Age
60%
Female
1.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data